samedan logo
 
 
 
spacer
home > pmps > summer 2018 > pharma flourishing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharma Flourishing

“Welcome to CPhI Worldwide 2018! The event returns in what has been a particularly successful year for pharmaceuticals. As an industry, we have seen a truly stellar year for new drugs – with an outstanding 46 FDA approvals in 2017 and many more to come. With the approval of Luxturna heralding a new age of fast-tracked gene therapies, growth in artificial intelligence, and advances in 3D printing, pharma is expecting a time of even greater collaboration and innovation. This year, with more on-site content than ever before, we look forward to welcoming our guests and providing a platform for building relationships that drive business growth,” says Orhan Caglayan, Brand Director Europe, at UBM (part of Informa).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

SIRIO launches first ‘smart nutra factory’ in Ma’anshan

Ma’anshan, 17 November 2020: SIRIO – a leading nutraceutical contract development and manufacturing organisation (CDMO) – has completed a new ‘smart factory’ at its Ma’anshan site, with Internet of Things (IoT) enabled automated processes and monitoring, intelligent distribution robotics and Artificial intelligence (AI).
More info >>

White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices

Phillips-Medisize

An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement